Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Single Arm, Unenhanced MRI-controlled Phase III Study for Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases Requiring MR Arthrography

NCT07057037 is registered in ClinicalTrials.gov with Inventera Inc. as lead sponsor.

NCT NCT07057037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07057037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Single Arm, Unenhanced MRI-controlled Phase III Study for Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases Requiring MR Arthrography
Lead sponsor
Inventera Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
September 23, 2025
Completion date
August 31, 2026
Enrollment
85 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

adhesive capsulitis, articular cartilage injury, glenohumeral ligament, labral tear, long head biceps tendon tear, rotator cuff tear, rotator cuff tendinosis, rotator cuff tendonitis